Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$nwbo](/topic/$nwbo)

### Top Social Posts

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"๐ŸฉธHow $NWBO Integrated Platelet Biology Dendritic Cell Licensing and a Silent Immune Engine Estimated Reading Time: 1012 minutes ๐Ÿงช TL;DR: The Engine Behind the Silence Mill Creeks PLTMax produces pooled tumor lysate rich in vascular antigens. Mayo proved the lysate works when combined with dendritic cells prepared using Northwest Biotherapeutics method. The trial succeeded without naming the company but the immune engine was theirs. Mill Creek owns the reagent. Mayo confirmed the system. Northwest Biotherapeutics owns the method. Flaskworks automates it. SI XX enables delivery. The trial"  
[@andrewcaravello](/creator/x/andrewcaravello) on [X](/post/tweet/1946078002950873340) 2025-07-18 05:22:06 UTC 1069 followers, 2968 engagements


"$NWBO I guess I thought @adamfeuerstein s biggest fears were atherosclerosis diabetes and stroke; turns out its when someone walks by his office building ๐Ÿซฃ๐Ÿ˜‚๐Ÿ˜‚"  
[@CaliLerone](/creator/x/CaliLerone) on [X](/post/tweet/1946048599365738938) 2025-07-18 03:25:16 UTC XXX followers, 1647 engagements


"In case someone has further interest M7 protocol was mentioned in the following paper. With the breakthrough of this magnitude should Merck acquire Oncovir and all the other ingredients complementary to DCVax-L long time ago push $NWBO to bankruptcy and pick up all the relevant IPs long time ago It is just such a commonsense question some longs forgot to ask. Anatomy of a deal: How Merck closed Immune Design for $300M"  
[@d_stock07734](/creator/x/d_stock07734) on [X](/post/tweet/1946004917379891543) 2025-07-18 00:31:41 UTC XXX followers, 1843 engagements


"DCVax-L does not cherry-pick off-the-shelf antigens. DCVax-L targets ALL the cancer tumor antigens present in YOUR resected tumor. Tumor heterogeneity is an issue for vaccines that only target one or some. ๐Ÿ‘Š๐Ÿ‘Š๐Ÿ‘Š๐Ÿ‘Š๐Ÿ‘Š๐Ÿ‘Š #FreezeYourTumor #GetDCVax $nwbo #dcvax #glioblastoma #gbm"  
[@sharpie510](/creator/x/sharpie510) on [X](/post/tweet/1945977371770962397) 2025-07-17 22:42:14 UTC XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$nwbo

Top Social Posts

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"๐ŸฉธHow $NWBO Integrated Platelet Biology Dendritic Cell Licensing and a Silent Immune Engine Estimated Reading Time: 1012 minutes ๐Ÿงช TL;DR: The Engine Behind the Silence Mill Creeks PLTMax produces pooled tumor lysate rich in vascular antigens. Mayo proved the lysate works when combined with dendritic cells prepared using Northwest Biotherapeutics method. The trial succeeded without naming the company but the immune engine was theirs. Mill Creek owns the reagent. Mayo confirmed the system. Northwest Biotherapeutics owns the method. Flaskworks automates it. SI XX enables delivery. The trial"
@andrewcaravello on X 2025-07-18 05:22:06 UTC 1069 followers, 2968 engagements

"$NWBO I guess I thought @adamfeuerstein s biggest fears were atherosclerosis diabetes and stroke; turns out its when someone walks by his office building ๐Ÿซฃ๐Ÿ˜‚๐Ÿ˜‚"
@CaliLerone on X 2025-07-18 03:25:16 UTC XXX followers, 1647 engagements

"In case someone has further interest M7 protocol was mentioned in the following paper. With the breakthrough of this magnitude should Merck acquire Oncovir and all the other ingredients complementary to DCVax-L long time ago push $NWBO to bankruptcy and pick up all the relevant IPs long time ago It is just such a commonsense question some longs forgot to ask. Anatomy of a deal: How Merck closed Immune Design for $300M"
@d_stock07734 on X 2025-07-18 00:31:41 UTC XXX followers, 1843 engagements

"DCVax-L does not cherry-pick off-the-shelf antigens. DCVax-L targets ALL the cancer tumor antigens present in YOUR resected tumor. Tumor heterogeneity is an issue for vaccines that only target one or some. ๐Ÿ‘Š๐Ÿ‘Š๐Ÿ‘Š๐Ÿ‘Š๐Ÿ‘Š๐Ÿ‘Š #FreezeYourTumor #GetDCVax $nwbo #dcvax #glioblastoma #gbm"
@sharpie510 on X 2025-07-17 22:42:14 UTC XXX followers, XXX engagements

$nwbo
/topic/$nwbo/posts